Hydrochloric Acid → HCID 70980027, compound
Reaction equation
C(O[C:6](=O)[N:7](C)[C@H:8]([C:10](=[O:24])[NH:11][C:12]1[CH:13]=[CH:14][C:15]2[NH:20][C:19](=[O:21])[C@H:18]([CH3:22])[NH:17][C:16]=2[N:23]=1)[CH3:9])(C)(C)C.[ClH:27]>>[ClH:27].[CH3:6][NH:7][C@@H:8]([CH3:9])[C:10]([NH:11][C:12]1[CH:13]=[CH:14][C:15]2[NH:20][C:19](=[O:21])[C@H:18]([CH3:22])[NH:17][C:16]=2[N:23]=1)=[O:24]Participants
3
Procedure
Methyl-[(S)-1-((S)-3-methyl-2-oxo-1,2,3,4-tetrahydro-pyrido[2,3-b]pyrazin-6-ylcarbamoyl)-ethyl]-carbamic acid tert-butyl ester (30 mg, 0.08 mmol) was treated with HCl according to the General procedure 3 (HCl deprotection) to afford the title compound (15 mg). 1H NMR (400 MHz, Me-d3-OD): 7.25 (1H, d), 6.91 (1H, d), 4.43-4.32 (1H, m), 4.12 (1H, d), 2.79 (3H, s), 1.67 (3H, d), 1.53 (3H, d). MS: [M+H]+=264.
Sources & evidence
- ORD record
- ord-d3a90c22a331417097ce94b7e566ba0c
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09155743B2
Reaction notes
Loading…